Results 271 to 280 of about 164,764 (309)

Seven new HLA‐B alleles associated with antigens in the B7 CREG

Tissue Antigens, 2002
Abstract: This paper describes seven novel HLA‐B alleles. Five of these new alleles contain polymorphic motifs previously reported in HLA‐B alleles, suggesting an origin resultant from a gene conversion mechanism. B*0723 contains a polymorphism previously unreported in class I HLA molecules.
C P, Gans, W, Mitton, J, Ng, R J, Hartzman, Carolyn Katovich, Hurley   +4 more
openaire   +2 more sources

A monoclonal antibody against an epitope common to HLA-B locus antigens

Human Immunology, 1982
A monoclonal antibody G4 that appears to be directed against a determinant common to all HLA-B locus antigens is described. This antibody reacted with a large panel of B and T lymphocyte and cell lines, but it did not react with two lines that do not serologically express HLA antigens (Daudi and K562) and two lines that expressed A-locus but not B ...
R, Billing, K, Lucero
openaire   +2 more sources

HLA-B∗0702 antibody epitopes are affected indirectly by distant antigen residues

Human Immunology, 1993
We examine the effect of mutations in the HLA-B*0702 alpha 1 domain on the binding of several well-characterized monoclonal antibodies. BB7.1 recognizes the alpha-helix, with a special requirement for residue 67. Combined with an established requirement for the alpha 2 alpha-helix, BB7.1 appears to span the B*0702 peptide-binding groove. Alternatively,
J A, McCutcheon, K D, Smith, A, Valenzuela, K, Aalbers, C T, Lutz   +4 more
openaire   +2 more sources

Nucleotide sequence analysis of HLA-B∗1523 and B∗8101 dominant α-helical motifs produce complex serologic recognition patterns for the HLA-B “DT” and HLA-B “NM5” antigens

Human Immunology, 1995
Assigning a precise serologic specificity to the class I HLA-B"NM5" and HLA-B"DT" molecules has proven difficult, with patterns of serologic cross-reactivity suggesting that NM5 is most like antigens in the B5 CREG and that DT is either B7 or B40 like.
M E, Ellexson, G, Zhang, D, Stewart, M, Lau, G, Teresi, P, Terasaki, B, Roe, W, Hildebrand   +7 more
openaire   +2 more sources

HLA‐B POT: a new HLA‐antigen within the B7‐cross reactive group

Tissue Antigens, 1986
In this report, a new HLA‐B locus antigen is described (tentatively called POT). The antigen has been identified with antisera against the antigens that belong to the B7‐cross reacting group.In a collaborative study, based on exchange of cells and sera, it was confirmed by population and family studies that the antigen is distinct from B7, Bw42 or Bw73
Reekers, Paul, van der Beucken, M., Andrien, Marc, Beelen, Josée, Mueller‐Eckhardt, Gertrud, Th. Schreuder, Geziena G.M.   +5 more
openaire   +3 more sources

Twenty‐nine new HLA‐B alleles associated with antigens in the 5C CREG

Tissue Antigens, 2001
Abstract: This paper describes 29 novel HLA‐B locus alleles identified during low‐resolution typing. The majority of the novel alleles carry new patterns of previously known polymorphic motifs or codons. Three alleles carry alterations in the Bw4/Bw6 epitope. Five alleles carry novel substitutions.
N K, Steiner, C, Kosman, P F, Jones, C P, Gans, S G, Rodriguez-Marino, G, Rizzuto, L A, Baldassarre, S, Edson, R, Koester, D, Sese, W, Mitton, J, Ng, R J, Hartzman, C K, Hurley   +13 more
openaire   +2 more sources

Synthesis of three peptides from HLA-A and HLA-B antigens

Collection of Czechoslovak Chemical Communications, 1991
Article without ...
Miroslava Žertová, Zdenko Procházka
openaire   +1 more source

HLA-A and HLA-B Antigens in Transitional Cell Carcinoma of the Bladder

Journal of Urology, 1979
A possible association between HLA-A and HLA-B loci alleles and bladder carcinoma has been investigated in 44 patients with biopsy proved transitional cell carcinoma of the bladder. The patients were compared to 400 healthy controls and matched for ethnic origin.
Z F, Braf, E, Gazit, M, Many
openaire   +2 more sources

False Positive and False Negative Reactions in HLA B‐27 Antigen Testing

Transfusion, 1979
The recent commercial availability of HLA B‐27 antiserum now enables laboratories without prior experience in HLA typing to test for this antigen. False positive and false negative reactions frequently occur and require judicious interpretation. In our laboratory, 30 of 100 specimens were positive for B‐27 and 70 were negative. Of the 30 positives, 10 (
openaire   +2 more sources

HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical

Transplantation, 2005
Although several risk factors for posttransplant lymphoproliferative disease (PTLD) after solid organ transplantation have been identified, the immunosuppressive regimen probably as most important one, their exact pathogenic role and relevance is still unclear. In hematopoietic stem cell transplantation, HLA mismatching also is a risk factor.
Bakker, Nicolaas A., van Imhoff, Gustaaf W., Verschuuren, Erik A. M., van Son, Willem J., Homan van der Heide, Jaap J., Lems, Simon P. M., Veeger, Nic J. G. M., Kluin, Philip M., Kluin-Nelemans, Hanneke C., Hepkema, Bouke G.   +9 more
openaire   +3 more sources